Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
The Journal of Clinical Psychiatry|January 1, 1997
Mixed anxiety and depression: from theory to practiceJ P Boulenger, M Fournier, D Rosales, et al.Clinical Neuropharmacology|January 1, 1986
Stress and caffeine: effects on central adenosine receptorsJ P Boulenger, P J Marangos, K J Zander, et al.Molecular Pharmacology|July 1, 1982
Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864P J Marangos, J Patel, J P Boulenger, et al.Bulletin Du Cancer|January 1, 1991
[Five years survival after treatment of gallbladder metastasis of malignant melanoma]P Y Bugnon, B Servais, P Boulenger-Bugnon, et al.Pharmacopsychiatry|September 1, 1991
Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled studyP Lemoine, J P Boulenger, V Caillard, et al.Current Medical Research and Opinion|January 14, 2010
Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetineJ P Boulenger, A Hermes, A K T Huusom, et al.Psychiatry Research|July 1, 1987
Plasma adenosine levels: measurement in humans and relationship to the anxiogenic effects of caffeineJ P Boulenger, N Salem, P J Marangos, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 26, 2004
Psychiatric morbidity, disability and service use amongst primary care attenders in FranceJ Norton, G de Roquefeuil, A Benjamins, et al.Archives of General Psychiatry|November 1, 1984
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidenceJ P Boulenger, T W Uhde, E A Wolff, et al.The Journal of Nervous and Mental Disease|February 9, 2000
Outcomes in a referral cohort of patients with anxiety disordersJ McCusker, J P Boulenger, F Bellavance, et al.Pageof 9